Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia

Psychopharmacology

Volumn 182, Issue 4, 2005, Pages 494-498

  Dakhale, G N ^a   Khanzode, S D ^a,b   Khanzode, S S ^a   Saoji, A ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b Venkatesh Apartment   (India)

Author keywords

Atypical antipsychotics; BPRS score; Oxidative stress; Schizophrenia; Vitamin C

Indexed keywords

ASCORBIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; MALONALDEHYDE; OLANZAPINE; PHOSPHOTUNGSTIC ACID; QUETIAPINE; REAGENT; ZIPRASIDONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ASCORBIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 26844535408     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0117-1     Document Type: Article

References (24)

1. Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F (2000) Erythrocyte superoxide dismutase and glutathion paraoxidase activities and malondealdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med 38:1277-1281
2. Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP (2003a) Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 53:56-64
3. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP (2003b) Supplementation with a combination of omega 3 fatty acids and antioxidants (vitamin E and C) improves the outcome of schizophrenia. Schizophr Res 62:195-204
4. Aye K (1978) A simple colorimetric method for ascorbic acid determination in blood plasma. Clin Chim Acta 86:153-157
5. Blakely RD, Wages SA, Justice JB, Hernbon JB, Neill DB (1984) Neuroleptics increase striatal catecholamines metabolites but not ascorbic acid in dialyzed perfusate. Brain Res 308:1-6
6. Cadet JL, Brannock C (1997) Invited review-free radicals and pathobiology of brain dopamine system. Neurochem Int 32:117-131
7. Cadet JL, Lohr JB (1987) Free radicals and developmental biopathology of schizophrenic burnout. Integr Psychiatr 51:40-48
8. Dakhale G, Khanzode SD, Khanzode SS, Saoji A, Khobragade L, Turankar A (2004) Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49:205-209
9. Englard S, Seifter S (1986) The biochemical functions of ascorbic acid. Annu Rev Nutr 6:365-406
10. Fridovich I (1983) Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 23:239-257
11. Hadjiconstanttinou M, Neff NH (1983) Ascorbic acid could be hazardous to your experiments: a commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal function. Neuropharmacology 22:939-946
12. Kei S (1978) Lipid peroxides in cerebrovascular disorders determined by new colorimetric method. Clin Chim Acta 90:37-43
13. Kuloghi M, Ustundag B, Atmaca M, Canatan H, Tezean AE, Cinkiline N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20:171-175
14. Liu J, Mori A (1993) Monoamine metabolism provides an antioxidant defense in the brain against oxidant and free radical induced damage. Arch Biochem Biophys 302:118-127
15. Mahadik SP, Mukherjee S, Correnti I, Sheffer R (1995) Elevated levels of lipid peroxidation products in plasma from drug-naive patients at onset of psychosis. Schizophr Res 15:66-70
16. Oke AI, May L, Adams RN (1987) Ascorbic acid distribution pattern in human brain. In: Bums JJ, Reverse JM, Machlin LJ (eds) Third conference on Vit C. Ann NY Acad Sci pp 1-12
17. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799-812
18. Padh H (1990) Cellular functions of ascorbic acid. Biochem Cell Biol 68:1166-1173
19. Reddy R, Mahadik SP, Mukherjee M, Murty JN (1991) Enzymes of the antioxidant system in chronic schizophrenic patients. Biol Psychiatry 30:409-412
20. Sen CK, Hanninen O (1994) Physiological antioxidants. In: Sen CK, Packer L, Hanninen O (eds) Exercise and oxygen toxicity. Elsevier Science Publishers, B.V., Amsterdam
21. Seregi A, Schaefer A, Komlos M (1978) Protective role of brain ascorbic acid content against lipid peroxidation. Experientia 34:1056-1057
22. Vaiva G, Thomas P, Leroux JM (1994) Erythrocyte superoxide dismutase determination in positive moments of psychosis. Therapie 49:343-348
23. Vera JC, Rivas CI, Fischbarg J (1993) Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364:79-82
24. Washko PW, Wanw Y, Levine M (1993) Ascorbic acid recycling in human neutrophils. J Biol Chem 268:15531-15535